Publicis Health snaps up R&D marketing group tracking real-world clinical trials – and patient sentiment
As biotechs move to adopt pharma-style marketing, Publicis Health is buying a biotech marketing and clinical trial enrollment company. Its purchase of BBK Worldwide adds real-world clinical trial data but also patient sentiment, along with technology to advance the smaller company’s “high touch high tech” approach in clinical trial engagement.
Publicis Health’s move follows changes in pharma and biotech marketing as Big Pharma demands more data and marketing plans from biotechs before potential acquisitions, while more smaller biotechs are taking drugs to market on their own.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.